Paul W levitra user reviews . Armstrong, M.D., Anthony H. Gershlick, M.D., Patrick Goldstein, M.D., Robert Wilcox, M.D., Thierry Danays, M.D., Yves Lambert, M.D., Vitaly Sulimov, M.D., Ph.D., Fernando Rosell Ortiz, M.D., Ph.D., Miodrag Ostojic, M.D., Ph.D., Robert C. Welsh, M.D., Antonio C. Carvalho, M.D., Ph.D., John Nanas, M.D., Ph.D., Hans-Richard Arntz, M.D., Ph.D., Sigrun Halvorsen, M.D., Ph.D., Kurt Huber, M.D., Stefan Grajek, M.D., Ph.D., Claudio Fresco, M.D., Erich Bluhmki, M.D., Ph.D., Anne Regelin, Ph.D., Katleen Vandenberghe, Ph.D., Kris Bogaerts, Ph.D., and Frans Van de Werf, M.D., Ph.D.
It is consequently no surprise that the most inventive ways to game the peer-review program to get manuscripts released attended from China. The companies mentioned above that provide fake peer evaluations all result from China and countries in Southeast Asia, and most of the authors involved in these full cases result from the same areas. But it would be a mistake to check out this simply because a Asian or Chinese problem. The nagging problem may be the perverse incentive systems in scientific publishing. Provided that authors are rewarded for publishing many content articles and editors are rewarded for publishing them quickly, new ways of gaming the original publication models will be invented more quickly than new control measures can be put in place..